1. Home
  2. CASI vs GLE Comparison

CASI vs GLE Comparison

Compare CASI & GLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • GLE
  • Stock Information
  • Founded
  • CASI 1991
  • GLE 2018
  • Country
  • CASI China
  • GLE Hong Kong
  • Employees
  • CASI N/A
  • GLE N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • GLE
  • Sector
  • CASI Health Care
  • GLE
  • Exchange
  • CASI Nasdaq
  • GLE NYSE
  • Market Cap
  • CASI 35.0M
  • GLE 33.1M
  • IPO Year
  • CASI 1996
  • GLE 2024
  • Fundamental
  • Price
  • CASI $2.21
  • GLE $1.64
  • Analyst Decision
  • CASI Strong Buy
  • GLE
  • Analyst Count
  • CASI 1
  • GLE 0
  • Target Price
  • CASI $6.00
  • GLE N/A
  • AVG Volume (30 Days)
  • CASI 8.1K
  • GLE 49.7K
  • Earning Date
  • CASI 03-27-2025
  • GLE 11-01-2024
  • Dividend Yield
  • CASI N/A
  • GLE N/A
  • EPS Growth
  • CASI N/A
  • GLE N/A
  • EPS
  • CASI N/A
  • GLE 0.02
  • Revenue
  • CASI $22,055,000.00
  • GLE $6,333,093.00
  • Revenue This Year
  • CASI N/A
  • GLE N/A
  • Revenue Next Year
  • CASI $134.79
  • GLE N/A
  • P/E Ratio
  • CASI N/A
  • GLE $95.31
  • Revenue Growth
  • CASI N/A
  • GLE 10.67
  • 52 Week Low
  • CASI $2.04
  • GLE $1.05
  • 52 Week High
  • CASI $7.67
  • GLE $5.44
  • Technical
  • Relative Strength Index (RSI)
  • CASI 35.91
  • GLE N/A
  • Support Level
  • CASI $2.15
  • GLE N/A
  • Resistance Level
  • CASI $2.49
  • GLE N/A
  • Average True Range (ATR)
  • CASI 0.15
  • GLE 0.00
  • MACD
  • CASI 0.00
  • GLE 0.00
  • Stochastic Oscillator
  • CASI 35.42
  • GLE 0.00

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About GLE GLOBAL ENGINE GROUP HOLDING LIMITED

Global Engine Group Holding Ltd offers integrated solutions by using ICT solutions to drive business outcomes and innovation. Its service offerings comprise services to telecom operators, including the one-stop shop purchase from telecom license application service to turnkey network setup as well as service outsourcing; business planning, development, technical and operations consulting programs structured to target the cloud computing and data center providers; system design, planning, development and operation services to technology companies; cloud platform deployment, IT system design and configuration services, maintenance services, data center colocation service and cloud service.

Share on Social Networks: